News stories about Innophos (NASDAQ:IPHS) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innophos earned a daily sentiment score of 0.07 on Accern’s scale. Accern also assigned media coverage about the specialty chemicals company an impact score of 47.7661086835611 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Innophos traded up $0.05, reaching $44.05, during trading hours on Friday, according to Marketbeat.com. 67,003 shares of the company’s stock were exchanged, compared to its average volume of 79,513. The firm has a market cap of $862.77 million, a PE ratio of 17.91 and a beta of 0.74. Innophos has a one year low of $38.66 and a one year high of $51.34. The company has a debt-to-equity ratio of 0.99, a current ratio of 2.75 and a quick ratio of 1.34.
Innophos (NASDAQ:IPHS) last announced its quarterly earnings data on Monday, July 30th. The specialty chemicals company reported $0.55 EPS for the quarter, missing the Zacks’ consensus estimate of $0.65 by ($0.10). The firm had revenue of $206.73 million during the quarter, compared to the consensus estimate of $213.40 million. Innophos had a net margin of 2.21% and a return on equity of 14.28%. The firm’s quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.57 earnings per share. equities analysts expect that Innophos will post 2.79 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 5th. Stockholders of record on Friday, August 17th will be paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.36%. The ex-dividend date is Thursday, August 16th. Innophos’s dividend payout ratio (DPR) is currently 78.05%.
IPHS has been the topic of a number of recent research reports. BidaskClub upgraded Innophos from a “strong sell” rating to a “sell” rating in a research note on Tuesday, April 24th. Zacks Investment Research upgraded Innophos from a “sell” rating to a “hold” rating in a research note on Wednesday, April 25th. Finally, TheStreet upgraded Innophos from a “c+” rating to a “b” rating in a research note on Wednesday, May 30th.
Innophos Company Profile
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
See Also: Stock Symbols and CUSIP Explained
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.